ストックスクリーナーアプリを入手
1.33
8.90%
-0.13
アフターアワーズ：
1.30
-0.03
-2.26%
前日終値:
$1.46
開ける：
$1.39
24時間の取引高:
1.74M
Relative Volume:
0.12
時価総額：
$226.96M
収益：
-
当期純損益:
$-63.55M
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
$-9.56M
1週間 パフォーマンス:
-4.32%
1か月 パフォーマンス:
-22.67%
6か月 パフォーマンス:
+62.20%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$1.32
$1.45
1週間の範囲:
$1.32
$1.91
52週間の値動き範囲:
$0.2556
$9.51
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
名前
Tevogen Bio Holdings Inc
セクター
電話
646-807-8832
住所
15 INDEPENDENCE BOULEVARD, SUITE 410, WARREN
TVGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| TVGN | 1.33 | 226.96M | 0 | -63.55M | -9.56M | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Tevogen Bio Holdings Inc (TVGN) 最新ニュース
UPDATETevogen Founder Reflects on Importance of - GlobeNewswire
Tevogen Founder Reflects on Importance of Preserving - GlobeNewswire
Tevogen Bio Achieves $40M Cost Efficiency While Building Biotech Portfolio | TVGN Stock News - StockTitan
Tevogen Bio Shares Are On The Rise Monday: What's Going On? - Benzinga
Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in Healthcare - Yahoo Finance
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations - The Manila Times
Tevogen Bio Nears Finalization of Agreement to Enhance R&D - GlobeNewswire
Tevogen Bio Secures $36M Credit Line, Expands Manufacturing With Strategic Deal | TVGNW Stock News - StockTitan
Tevogen Bio partners Microsoft for HPV treatment - Yahoo! Voices
Tevogen Bio Holdings Inc (TVGN-Q) QuotePress Release - The Globe and Mail
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success through Patient Affordability - The Manila Times
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigio - WICZ
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability - GlobeNewswire
TVGNTevogen Bio Holdings Inc. Latest Stock News & Market Updates - StockTitan
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920 - The Manila Times
Tevogen Bio advances HPV oncology treatment TVGN 920 By Investing.com - Investing.com UK
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine L - WICZ
Tevogen Bio Teams with Microsoft AI to Fast-Track HPV Cancer Treatment Development | TVGN Stock News - StockTitan
Tevogen Bio Announces Appointment of Anthony Tarantino as - GlobeNewswire
Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support - Yahoo Finance
Tevogen Bio Holdings Inc. Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs - Marketscreener.com
Tevogen partners with Microsoft to speed up drug development By Investing.com - Investing.com Australia
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs - The Manila Times
Tevogen Bio Expands on Microsoft Partnership to Integrate - GlobeNewswire
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company - The Manila Times
Tevogen Bio Reports Nasdaq Listing Compliance as CEO - GlobeNewswire
Tevogen Bio Signs Letter of Intent With CD8 Technology to - GlobeNewswire
Tevogen Bio plans new R&D and manufacturing facility By Investing.com - Investing.com UK
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity - StockTitan
Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market SessionKoninklijke Philips (NYSE:PHG) - Benzinga
Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas - ForexTV.com
Tevogen Bio Provides Additional Guidance on Introduction of - GlobeNewswire
Tevogen Bio (NASDAQ:TVGN) Shares Gap DownShould You Sell? - MarketBeat
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Up 450.9% in October - MarketBeat
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Tevogen Bio Shares Are Soaring Wednesday: What's Going On? - MSN
Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph
Tevogen Bio's Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - The Manila Times
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen - GlobeNewswire
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - StockTitan
Tevogen Bio To Provide Timelines Associated with Recently - GlobeNewswire
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week - GlobeNewswire Inc.
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy - GlobeNewswire
Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion - The Manila Times
Tevogen Bio Specialty Care Reports Top-Line Revenue - GlobeNewswire
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days - StockTitan
Teucrium Wheat (WEAT-A) QuotePress Release - The Globe and Mail
Insider Selling: Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Insider Sells 1,078,600 Shares of Stock - MarketBeat
20% Of This Tevogen Bio Holdings Insider's Holdings Were Sold - Simply Wall St
Tevogen says CSO share sale ‘solely’ to satisfy payment of tax obligations - TipRanks
Tevogen bio holdings chief scientific officer sells shares worth $1.75 million - Investing.com UK
Tevogen Bio Holdings Inc (TVGN) 財務データ
収益
当期純利益
現金流量
EPS
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):